Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Diclofenac sodium 100 mg Tablet, modified release Apotex Inc., Weston, Ontario, Canada Apo-Diclofenac SR Mycophenolate mofetil hydrochloride 542 mg equivalent to 500 mg mycophenolate mofetil Infusion, powder Parkedale Pharmaceuticals, Rochester, Michigan, United States of America Cellcept Recombinant human erythropoietin 2000IU/mL, 3000IU/mL, 4000IU/mL, 10000IU/mL Injection, solution (vial) F Hoffman-La Roche Limited, Basle, Switzerland and Janssen Pharmaceutica nv., Beerse, Belgium Eprex (citrate buffered) Recombinant human erythropoietin 2000IU/mL, 4000IU/mL, 10000IU/mL Injection, solution (pre-filled syringe) Janssen Pharmaceutica nv., Beerse, Belgium; Cilag AG, Schaffhausen, Switzerland and Vetter Pharm-Fertigung GmbH & Co Kg., Ravensburg, Germany Eprex (phosphate buffered) Recombinant human erythropoietin 2000IU/mL, 4000IU/mL, 10000IU/mL Injection, solution (vial) Janssen Pharmaceutica nv., Beerse, Belgium and Cilag AG, Schaffhausen, Switzerland Eprex (phosphate buffered) Recombinant human erythropoietin 4000IU/mL, 10000IU/mL, 20000IU/mL Injection, solution (multidose vial) F Hoffman-La Roche Limited, Basle, Switzerland Eprex (phosphate buffered) Nadroparin calcium 19000 anti-Xa IU/mL Injection, solution Sanofi Winthrop Industrie, Notre Dame de Bondeville, France Fraxiparine Forte Cefodizime disodium 250 mg, 500 mg, 1000 mg, 2000 mg Injection, powder Hoechst Marion Roussel, Frankfurt am Main, Germany Timecef Cefodizime disodium 1000 mg, 2000 mg Infusion, powder Hoechst Marion Roussel, Frankfurt am Main, Germany Timecef Dated this 13th day of October 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.